Glutamate in schizophrenia: clinical and research implications

This publication has 83 references indexed in Scilit:

• Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics
  Journal of Neuroscience, 1996
• Editing for an AMPA receptor subunit RNA in prefrontal cortex and striatum in Alzheimer's disease, Huntington's disease and schizophrenia
  Brain Research, 1995
• Glutamate receptor subtype expression in human postmortem brain tissue from schizophrenics and alcohol abusers
  Brain Research, 1995
• d-Cycloserine adjuvant therapy to conventional neuroleptic treatment in schizophrenia: an open-label study
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1994
• Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?
  Annals of Neurology, 1992
• The association among negative symptoms, movement disorders, and frontal lobe psychological deficits in schizophrenic patients
  Biological Psychiatry, 1991
• Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease
  Trends in Neurosciences, 1990
• An Open Trial of Glycine as an Adjunct to Neuroleptics in Chronic Treatment-Refractory Schizophrenics
  Journal of Clinical Psychopharmacology, 1990
• Glutamate neurotoxicity and diseases of the nervous system
  Neuron, 1988
• Plasma Amino Acids in Relation to Cerebrospinal Fluid Monoamine Metabolites in Schizophrenic Patients and Healthy Controls
  The British Journal of Psychiatry, 1985